_tif.png)
About Us
Order-made Medical Research Inc. (OMR) is a biotech company promoting technology development that revolutionize therapeutic antibodies.
We have made it possible to generate prominent antibodies against multi-transmembrane target molecules that have been difficult to create and have succeeded in expanding the number of target molecules extremely for therapeutic antibodies. Furthermore, as a further application development, we are challenging to create innovative therapeutic antibodies targeted intracellular molecules and disease-specific immunogenicity changes that have been difficult to target antibodies.
We will pursue business to explore target molecules for therapeutic antibodies and generate them to out-license them to pharmaceuticals and biotech companies at the early stages of R&D.
Philosophy
Order-made Medical Research Inc. (OMR) is a biotech company promoting technology development that revolutionize therapeutic antibodies.
We have made it possible to generate prominent antibodies against multi-transmembrane target molecules that have been difficult to create and have succeeded in expanding the number of target molecules extremely for therapeutic antibodies. Furthermore, as a further application development, we are challenging to create innovative therapeutic antibodies targeted intracellular molecules and disease-specific immunogenicity changes that have been difficult to target antibodies.
We will pursue business to explore target molecules for therapeutic antibodies and generate them to out-license them to pharmaceuticals and biotech companies at the early stages of R&D.
Company Profile
Company name
Order-made Medical Research Inc.
Representative
Representative Director and CEO Yasufumi Murakami
Head Office Location
5-5-4, Tokodai, Tsukuba-shi,
Ibaraki 300-2635 Japan
Capital
358 million yen
Establishment
April 23, 2012
Number of employees
11 people (as of May 2023)
Introduction of Founder
Yasufumi Murakami
President and CEO
Dr. Murakami is a founder and CEO of OMR. Research Fellow at Alberta Einstein Medical University, Immunology, Sloan-Kettering Commemorative Cancer Research Center, Molecular Biology and Virology Division. After engaging in research on antibody and genomic biology at RIKEN, he became professor of the Department of Biological Engineering at Tokyo University of Science and also served as a visiting professor at Tottori University, founded OMR in 2012. Graduated doctoral course at University of Tokyo (Pharmaceutical Science). Specialty fields are therapeutic antibody, genomic biology, genetic engineering.
Company History
Apr 2012
Established Order-made Medical Research, Inc. founded
Start from one room of student apartment adjacent to the Noda campus of Tokyo University of Science
2013
Santen Pharmaceutical Co., Ltd.
2013
Teijin Pharma Co., Ltd.
Apr 2015
Moved to Tokyo University Kashiwa Venture Plaza and relocated the headquarters
Sep 2016
R&D base has been relocated to Tsukuba-shi, Ibaraki
Dec 2016
Raised ¥ 300 million funds from RealTech Fund
Dec 2017
Signed a Joint R&D Agreement with Mitsubishi Tanabe Pharma
Nov 2021
R&D base has been relocated to Tsukuba-shi, Ibaraki
May 2023
Head office has been relocated to Tsukuba-shi, Ibaraki
Access
Order-made Medical Research Inc.
5-5-4, Tokodai, Tsukuba-shi, Ibaraki 300-2635 JAPAN
By train
1. Get off at Kenkyū-gakuen Station on the Tsukuba Express Line.
2. It takes about 7 minites by cab from the north exit of the station.
By car
-
It is about 8 km from the Yatabe Interchange on the Joban Expressway toward Tsukuba. When coming from the Ken-O Expressway, it is about 4 km from the Tsukuba-chuo Interchange in the direction of Gakuen City.
-
At the Omonoidai intersection, go toward Tokodai Research Park and turn left before ZOZOBASE Tsukuba 1.
-
Go straight for about 200 meters and our company is located at the left end of the lot on the left side.